Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Piercey

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Clinical Neuropharmacology|January 1, 1992
Intrinsic activity of DA agonistsR A Lahti, L M Figur, M F Piercey, et al.
Brain Research|August 21, 1992
Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232M F Piercey, J T Lum, W E Hoffmann, et al.
Brain Research|March 31, 1980
Morphine does not antagonize the substance P mediated excitation of dorsal horn neuronsM F Piercey, F J Einspahr, P J Dobry, et al.
Journal of Medicinal Chemistry|July 23, 1993
Novel 2-substituted tetrahydro-3H-benz[e]indolamines: highly potent and selective agonists acting at the 5-HT1A receptor as possible anxiolytics and antidepressantsA G Romero, J A Leiby, R B McCall, et al.
Brain Research|August 13, 1993
Antagonism of cocaine self-administration by the preferential dopamine autoreceptor antagonist, (+)-AJ 76N R Richardson, M F Piercey, K Svensson, et al.
Brain Research|January 28, 1994
Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomographyJ Blin, C A Ray, M F Piercey, et al.
Journal of Medicinal Chemistry|October 15, 1993
Substituted 3-phenylpiperidines: new centrally acting dopamine autoreceptor antagonistsC Sonesson, N Waters, K Svensson, et al.
Brain Research|May 22, 1995
Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complexF Calon, M Goulet, P J Blanchet, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeysP J Blanchet, F Calon, J C Martel, et al.
Research Communications in Chemical Pathology and Pharmacology|February 1, 1989
Animal behavioral and neurochemical effects of the CNS toxic amino acid antitumor agent, acivicinJ P McGovren, M G Williams, A H Tang, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Clinical Neuropharmacology|January 1, 1992
Intrinsic activity of DA agonistsR A Lahti, L M Figur, M F Piercey, et al.
Brain Research|August 21, 1992
Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232M F Piercey, J T Lum, W E Hoffmann, et al.
Brain Research|March 31, 1980
Morphine does not antagonize the substance P mediated excitation of dorsal horn neuronsM F Piercey, F J Einspahr, P J Dobry, et al.
Journal of Medicinal Chemistry|July 23, 1993
Novel 2-substituted tetrahydro-3H-benz[e]indolamines: highly potent and selective agonists acting at the 5-HT1A receptor as possible anxiolytics and antidepressantsA G Romero, J A Leiby, R B McCall, et al.
Brain Research|August 13, 1993
Antagonism of cocaine self-administration by the preferential dopamine autoreceptor antagonist, (+)-AJ 76N R Richardson, M F Piercey, K Svensson, et al.
Brain Research|January 28, 1994
Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomographyJ Blin, C A Ray, M F Piercey, et al.
Journal of Medicinal Chemistry|October 15, 1993
Substituted 3-phenylpiperidines: new centrally acting dopamine autoreceptor antagonistsC Sonesson, N Waters, K Svensson, et al.
Brain Research|May 22, 1995
Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complexF Calon, M Goulet, P J Blanchet, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeysP J Blanchet, F Calon, J C Martel, et al.
Research Communications in Chemical Pathology and Pharmacology|February 1, 1989
Animal behavioral and neurochemical effects of the CNS toxic amino acid antitumor agent, acivicinJ P McGovren, M G Williams, A H Tang, et al.
Pageof 9